Clinical course of the patients with spinocerebellar ataxia type 3/Machado-Joseph disease in the Hokuriku district in Japan

被引：0
|
作者：
Ishida, C. [1 ]
Motozaki, Y. [1 ]
Takahashi, K. [1 ]
Ikeda, T. [1 ]
Asakawa, M. [1 ]
Komai, K. [1 ]
机构：
[1] Natl Hosp Org Lou Hosp, Neurol, Kanazawa, Ishikawa, Japan
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2017年 / 381卷
关键词：
D O I：
10.1016/j.jns.2017.08.867
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
839
引用
收藏
页码：305 / 306
页数：2
相关论文
共 50 条
  • [21] Degeneration of the external cuneate nucleus in spinocerebellar ataxia type 3 (Machado-Joseph disease)
    Rüb, U
    de Vos, RAI
    Brunt, ER
    Schultz, C
    Paulson, H
    Del Tredici, K
    Braak, H
    BRAIN RESEARCH, 2002, 953 (1-2) : 126 - 134
  • [22] Machado-Joseph disease (Spinocerebellar ataxia type 3) and parasomnias: Correlation through polysomnography
    Pedroso, J. L.
    Silva, G. M. F.
    Santos, D. F.
    Prado, L. B. F.
    Carvalho, L. B.
    Barsottini, O.
    Prado, G. F.
    MOVEMENT DISORDERS, 2014, 29 : S479 - S480
  • [23] Peripheral Oxidative Stress Biomarkers in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease
    de Assis, Adriano M.
    Morales Saute, Jonas Alex
    Longoni, Aline
    Haas, Clarissa Branco
    Torrez, Vitor Rocco
    Brochier, Andressa Wigner
    Souza, Gabriele Nunes
    Furtado, Gabriel Vasata
    Gheno, Tailise Conte
    Russo, Aline
    Monte, Thais Lampert
    Castilhos, Raphael Machado
    Schumacher-Schuh, Artur
    D'Avila, Rui
    Donis, Karina Carvalho
    de Mello Rieder, Carlos Roberto
    Souza, Diogo Onofre
    Camey, Suzi
    Leotti, Vanessa Bielefeldt
    Jardim, Laura Bannach
    Portela, Luis Valmor
    FRONTIERS IN NEUROLOGY, 2017, 8
  • [24] Identification of a potential exosomal biomarker in spinocerebellar ataxia Type 3/Machado-Joseph disease
    Hou, Xiaocan
    Gong, Xuan
    Zhang, Longbo
    Li, Tianjiao
    Yuan, Hongyu
    Xie, Yue
    Peng, Yun
    Qiu, Rong
    Xia, Kun
    Tang, Beisha
    Jiang, Hong
    EPIGENOMICS, 2019, 11 (09) : 1037 - 1055
  • [25] Botulinum toxin type a for treatment of spasticity in spinocerebellar ataxia type 3 (Machado-Joseph disease)
    Freeman, W
    Wszolek, Z
    MOVEMENT DISORDERS, 2005, 20 (05) : 644 - 644
  • [26] Absence of spinocerebellar ataxia type 3/Machado-Joseph disease within ataxic patients in the Czech population
    Bauer, PO
    Zumrova, A
    Matoska, V
    Marikova, T
    Krilova, S
    Boday, A
    Singh, B
    Goetz, P
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 (11) : 851 - 857
  • [27] Vergence disorders in patients with spinocerebellar ataxia 3/Machado-Joseph disease: a synoptophore study
    Ohyagi, Y
    Yamada, T
    Okayama, A
    Sakae, N
    Yamasaki, T
    Ohshima, T
    Sakamoto, T
    Fujii, N
    Kira, J
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2000, 173 (02) : 120 - 123
  • [28] Spinocerebellar ataxia type 3 (Machado-Joseph disease):: severe destruction of the lateral reticular nucleus
    Rüb, U
    de Vos, RAI
    Schultz, C
    Brunt, ER
    Paulson, H
    Braak, H
    BRAIN, 2002, 125 : 2115 - 2124
  • [29] MRI T2-Relaxometry in Spinocerebellar Ataxia Type 3 (Machado-Joseph Disease)
    Silva, Beatriz
    Guimaraes, Rachel
    Bergo, Felipe
    Franca, Marcondes
    D'Abreu, Anelyssa
    Lopes-Cendes, Iscia
    Cendes, Fernando
    NEUROLOGY, 2012, 78
  • [30] MRI T2-relaxometry in spinocerebellar ataxia type 3 (Machado-Joseph disease)
    Silva, B. H. B.
    Guimaraes, R.
    Bergo, F.
    Franca, M. C., Jr.
    D'Abreu, A. C. F.
    Lopes-Cendes, I.
    Cendes, F.
    MOVEMENT DISORDERS, 2012, 27 : S232 - S232
12345